Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

tempol × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Tumor-Agnostic 1 Other 1 Gastrointestinal 1 CNS 1

Conditions

Ototoxicity 1 Mucositis 1

Interventions

Exercise 24 Metformin 19 Surveys and Questionnaires 15 Methods 12 Early Intervention, Educational 11 Standard of Care 10 Radiotherapy 10 Educational Status 10 Counseling 10 naloxegol 8 Tirzepatide 8 Nutrition Assessment 8 Diet 8 Psychiatric Rehabilitation 7 Interviews as Topic 7 Diet Therapy 7 Therapeutics 6 Resistance Training 6 Cisplatin 6 Caloric Restriction 6 semaglutide 5 alvimopan 5 Radiation 5 Liraglutide 5 Exenatide 5 Diet, Mediterranean 5 Dexamethasone 5 Blood Specimen Collection 5 Bariatric Surgery 5 Specimen Handling 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03480971 2024-11-20

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Matrix Biomed, Inc.

Phase 2 Recruiting

Ototoxicity, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡